Literature DB >> 21392914

Comparison of capability of dynamic O₂-enhanced MRI and quantitative thin-section MDCT to assess COPD in smokers.

Yoshiharu Ohno1, Hisanobu Koyama, Takeshi Yoshikawa, Keiko Matsumoto, Nobukazu Aoyama, Yumiko Onishi, Daisuke Takenaka, Sumiaki Matsumoto, Yoshihiro Nishimura, Kazuro Sugimura.   

Abstract

PURPOSE: The purpose of this study was to directly and prospectively compare the capability of dynamic O(2)-enhanced MRI and quantitatively assessed thin-section MDCT to assess smokers' COPD in a large prospective cohort.
MATERIALS AND METHODS: The GOLD criteria for smokers were used to classify 187 smokers into four clinical stage groups as follows: smokers without COPD (n=56) and with mild (n=54), moderate (n=52) and severe or very severe COPD (n=24). All smokers underwent dynamic O(2)-enhanced MRI, MDCT and pulmonary function tests. Mean relative enhancement ratio and mean wash-in time on MRI and CT-based functional lung volume (CT-based FLV) as well as the ratio of airway wall area to total airway area on MDCT were computationally calculated. Then, all indexes were significantly correlated with functional parameters. To determine the efficacy of all indexes for clinical stage classification, the indexes for the four clinical groups were statistically compared by using Tukey's honestly significant difference multiple comparison test.
RESULTS: All indexes had significant correlations with functional parameters (p<0.0001). All indexes except CT-based FLV in all groups had significant differences each other (p<0.05).
CONCLUSIONS: Dynamic O(2)-enhanced MRI for assessment of COPD in smokers is potentially as efficacious as quantitatively assessed thin-section MDCT.
Copyright © 2011 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21392914     DOI: 10.1016/j.ejrad.2011.02.004

Source DB:  PubMed          Journal:  Eur J Radiol        ISSN: 0720-048X            Impact factor:   3.528


  7 in total

Review 1.  Hyperpolarized gas MRI in pulmonology.

Authors:  Agilo Luitger Kern; Jens Vogel-Claussen
Journal:  Br J Radiol       Date:  2018-01-22       Impact factor: 3.039

Review 2.  Morphological measurements in computed tomography correlate with airflow obstruction in chronic obstructive pulmonary disease: systematic review and meta-analysis.

Authors:  Xueqian Xie; Pim A de Jong; Matthijs Oudkerk; Ying Wang; Nick H T Ten Hacken; Jingtao Miao; Guixiang Zhang; Geertruida H de Bock; Rozemarijn Vliegenthart
Journal:  Eur Radiol       Date:  2012-06-15       Impact factor: 5.315

Review 3.  Overview of MRI for pulmonary functional imaging.

Authors:  Yoshiharu Ohno; Satomu Hanamatsu; Yuki Obama; Takahiro Ueda; Hirotaka Ikeda; Hidekazu Hattori; Kazuhiro Murayama; Hiroshi Toyama
Journal:  Br J Radiol       Date:  2021-02-02       Impact factor: 3.629

4.  Functional lung MRI in chronic obstructive pulmonary disease: comparison of T1 mapping, oxygen-enhanced T1 mapping and dynamic contrast enhanced perfusion.

Authors:  Bertram J Jobst; Simon M F Triphan; Oliver Sedlaczek; Angela Anjorin; Hans Ulrich Kauczor; Jürgen Biederer; Julia Ley-Zaporozhan; Sebastian Ley; Mark O Wielpütz
Journal:  PLoS One       Date:  2015-03-30       Impact factor: 3.240

5.  Influence of COPD Assessment Text (CAT) evaluation and rehabilitation education guidance on the respiratory and motor functions of COPD patients.

Authors:  Jing Liu; Guangju Meng; Yi Ma; Xia Zhang; Dongmei Chen; Mengting Chen
Journal:  Open Med (Wars)       Date:  2015-12-17

6.  Comparison of efficiency of inhaled and intravenous corticosteroid on pregnant women with COPD and the effects on the expression of PCT and hs-CRP.

Authors:  Yuliang Zhao; Fei Li; Yangwen Liu; Yingjun Shi; Zhihai Li; Guangke Cao; Wang Zhu
Journal:  Exp Ther Med       Date:  2018-03-30       Impact factor: 2.447

Review 7.  State-of-the-art MR Imaging for Thoracic Diseases.

Authors:  Yumi Tanaka; Yoshiharu Ohno; Satomu Hanamatsu; Yuki Obama; Takahiro Ueda; Hirotaka Ikeda; Akiyoshi Iwase; Takashi Fukuba; Hidekazu Hattori; Kazuhiro Murayama; Takeshi Yoshikawa; Daisuke Takenaka; Hisanobu Koyama; Hiroshi Toyama
Journal:  Magn Reson Med Sci       Date:  2021-04-29       Impact factor: 2.760

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.